chr1-162772032-G-A
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBS1BS2
The NM_006182.4(DDR2):c.1513G>A(p.Gly505Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000479 in 1,607,024 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_006182.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DDR2 | NM_006182.4 | c.1513G>A | p.Gly505Ser | missense_variant | 13/18 | ENST00000367921.8 | NP_006173.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DDR2 | ENST00000367921.8 | c.1513G>A | p.Gly505Ser | missense_variant | 13/18 | 1 | NM_006182.4 | ENSP00000356898.3 | ||
DDR2 | ENST00000367922.7 | c.1513G>A | p.Gly505Ser | missense_variant | 14/19 | 1 | ENSP00000356899.2 | |||
DDR2 | ENST00000446985.6 | c.1513G>A | p.Gly505Ser | missense_variant | 13/18 | 3 | ENSP00000400309.2 | |||
DDR2 | ENST00000433757.1 | n.290G>A | non_coding_transcript_exon_variant | 3/3 | 3 |
Frequencies
GnomAD3 genomes AF: 0.00264 AC: 402AN: 152156Hom.: 2 Cov.: 33
GnomAD3 exomes AF: 0.000777 AC: 186AN: 239252Hom.: 1 AF XY: 0.000465 AC XY: 60AN XY: 129070
GnomAD4 exome AF: 0.000252 AC: 367AN: 1454750Hom.: 1 Cov.: 31 AF XY: 0.000234 AC XY: 169AN XY: 722994
GnomAD4 genome AF: 0.00265 AC: 403AN: 152274Hom.: 2 Cov.: 33 AF XY: 0.00282 AC XY: 210AN XY: 74454
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 30, 2023 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Sep 15, 2015 | - - |
DDR2-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 21, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at